This Dutch AI Startup Just Quietly Raised $2M to Transform Hearing Care

Jan de Vries · 2026-08-28

Here's something interesting I just came across. A startup out of the Netherlands, based in Maastricht, just landed a significant seed round. It's not another fintech or food delivery app—it's tackling a healthcare problem that affects billions, yet most of us rarely talk about. Clementine, which also goes by ClementineAI, secured $2 million in seed funding. The round was led by Healthy.Capital, an Amsterdam-based investor focused on early-stage health technology. They've got a solid track record, backing companies like Pharmi and OpenUp, so their vote of confidence here is worth noting. ### What Clementine Actually Does So, what's the big idea? The company has built what it calls the world's first AI hearing activation platform. Think of it as a bridge. For the millions of people with hearing loss, taking that first step into a clinic can be daunting. There's stigma, there's confusion, and frankly, there are long waiting lists. Clementine's platform is built around an AI agent named Matthew. This isn't just a chatbot. It's designed to engage prospective patients directly, answering their questions 24/7. The key is that it does this without judgment and without a wait. It educates, helps overcome emotional barriers, and guides people toward the appropriate care they need. Founder and CEO Vince van de Weijer put it simply: "Clinics don't need more leads; they need better conversations at the right moment." That's the gap Matthew fills. For clinics, it automates the initial admin, turning inquiries into actual bookings. For patients, it means a clearer, smoother path to better hearing. ### The Scale of the Problem Let's talk numbers for a second, because they're staggering. According to the company, hearing loss affects roughly 1.5 billion people globally. Here's the kicker: nearly 80% of those people never seek treatment. And for those who finally do? They typically wait over eight years from when they first notice a problem. Eight years. That's a massive gap between need and action. Clementine's approach pairs AI with behavioral science to meet people where they are—online, privately, and on their own time—long before they're ready to walk into a physical office. ### What's Next for the Startup This funding isn't happening in a vacuum. It comes right after Clementine expanded into North America through a partnership with Zoolstra, a marketing agency that works with hearing clinics across the United States and Canada. So they're already thinking globally. The new capital has a clear purpose: - Deepening the company's core AI capabilities - Expanding partnerships with hearing clinics - Building relationships with optical retailers and other healthcare organizations Douwe Jippes, managing partner at Healthy.Capital, highlighted why they invested: "Clementine combines deep domain expertise with a clear AI platform strategy that can scale globally. We believe this approach will fundamentally change how people with hearing disability engage with healthcare." It's a classic case of a startup using technology not to create a new market, but to finally serve an existing one that's been painfully underserved. They're not selling hearing aids; they're selling access, understanding, and a removal of friction. In a world where AI often feels abstract, this is a pretty concrete—and human—application. It'll be fascinating to see how this scales and whether this model can be applied to other areas of healthcare where stigma and long wait times are huge barriers.